The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
108881672 10888167 2 F 2012 20160912 20150304 20160920 EXP US-ASTRAZENECA-2013SE72651 ASTRAZENECA 71.00 YR M Y 102.10000 KG 20160920 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
108881672 10888167 1 PS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral DAILY 21153
108881672 10888167 2 SS BYDUREON EXENATIDE 1 Subcutaneous 73229 0 2 MG /wk
108881672 10888167 3 SS BYETTA EXENATIDE 1 Subcutaneous DOSE UNKNOWN U U 0 SOLUTION FOR INJECTION IN PRE-FILLED PEN
108881672 10888167 4 SS METOPROLOL ER METOPROLOL SUCCINATE 1 Oral 0 2000 MG MODIFIED-RELEASE TABLET QD
108881672 10888167 5 SS METOPROLOL ER METOPROLOL SUCCINATE 1 Oral 0 2000 MG MODIFIED-RELEASE TABLET QD
108881672 10888167 6 SS METOPROLOL ER METOPROLOL SUCCINATE 1 Oral DAILY 0 MODIFIED-RELEASE TABLET
108881672 10888167 7 SS METOPROLOL ER METOPROLOL SUCCINATE 1 Oral DAILY 0 MODIFIED-RELEASE TABLET
108881672 10888167 8 SS METOPROLOL ER METOPROLOL SUCCINATE 1 Oral 0 5 MG MODIFIED-RELEASE TABLET QD
108881672 10888167 9 SS METOPROLOL ER METOPROLOL SUCCINATE 1 Oral 0 5 MG MODIFIED-RELEASE TABLET QD
108881672 10888167 10 SS CARBOPLATIN. CARBOPLATIN 1 Unknown U 0 INJECTION
108881672 10888167 11 SS IFOSFAMIDE. IFOSFAMIDE 1 Unknown U 0
108881672 10888167 12 SS ETOPOSIDE. ETOPOSIDE 1 Unknown U 0 INJECTION
108881672 10888167 13 C COUMADIN WARFARIN SODIUM 1 0 TABLET
108881672 10888167 14 C XARELTO RIVAROXABAN 1 UNK 0
108881672 10888167 15 C XARELTO RIVAROXABAN 1 UNK 0
108881672 10888167 16 C XARELTO RIVAROXABAN 1 Oral DAILY 0
108881672 10888167 17 C XARELTO RIVAROXABAN 1 Oral DAILY 0
108881672 10888167 18 C DIGOXIN. DIGOXIN 1 Oral DAILY 0
108881672 10888167 19 C DIGOXIN. DIGOXIN 1 Oral 0 .25 MG QD
108881672 10888167 20 C PRADAXA DABIGATRAN ETEXILATE MESYLATE 1 Oral DAILY 0
108881672 10888167 21 C INSULIN SLIDING INJECTABLE 2 FOUR TIMES A DAY 0
108881672 10888167 22 C CIALIS TADALAFIL 1 Oral 0 5 MG QD
108881672 10888167 23 C LEVOTHYROXINE. LEVOTHYROXINE 1 Oral 0 100 MG QD
108881672 10888167 24 C FLOMAX TAMSULOSIN HYDROCHLORIDE 1 Oral DAILY 0
108881672 10888167 25 C MAGNESIUM MAGNESIUM 1 Oral 0 800 MG QD
108881672 10888167 26 C METFORMIN METFORMIN HYDROCHLORIDE 1 0 2000 MG QD
108881672 10888167 27 C NOVOLOG INSULIN ASPART 1 0
108881672 10888167 28 C SYNTHROID LEVOTHYROXINE SODIUM 1 0 112 UG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
108881672 10888167 1 Gastrooesophageal reflux disease
108881672 10888167 2 Type 2 diabetes mellitus
108881672 10888167 3 Type 2 diabetes mellitus
108881672 10888167 4 Atrial fibrillation
108881672 10888167 5 Diabetes mellitus
108881672 10888167 6 Atrial fibrillation
108881672 10888167 7 Diabetes mellitus
108881672 10888167 8 Atrial fibrillation
108881672 10888167 9 Diabetes mellitus
108881672 10888167 14 Atrial fibrillation
108881672 10888167 15 Anticoagulant therapy
108881672 10888167 16 Atrial fibrillation
108881672 10888167 17 Anticoagulant therapy
108881672 10888167 18 Atrial fibrillation
108881672 10888167 19 Atrial fibrillation
108881672 10888167 21 Diabetes mellitus
108881672 10888167 22 Benign prostatic hyperplasia
108881672 10888167 23 Hypothyroidism
108881672 10888167 24 Benign prostatic hyperplasia
108881672 10888167 25 Hypomagnesaemia
108881672 10888167 26 Type 2 diabetes mellitus
108881672 10888167 27 Type 2 diabetes mellitus

Outcome of event

Event ID CASEID OUTC COD
108881672 10888167 HO
108881672 10888167 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
108881672 10888167 Hodgkin's disease
108881672 10888167 Hypomagnesaemia
108881672 10888167 Injection site haemorrhage
108881672 10888167 Insulin resistance
108881672 10888167 Liver disorder
108881672 10888167 Respiratory tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
108881672 10888167 1 2012 0
108881672 10888167 2 201209 0
108881672 10888167 4 1980 0
108881672 10888167 5 1980 0
108881672 10888167 6 2000 0
108881672 10888167 7 2000 0
108881672 10888167 16 2013 0
108881672 10888167 17 2013 0
108881672 10888167 18 2005 0
108881672 10888167 20 2010 2013 0
108881672 10888167 21 1985 0
108881672 10888167 22 2013 0
108881672 10888167 23 1999 0
108881672 10888167 24 2010 0
108881672 10888167 25 2013 0
108881672 10888167 26 1980 0